Clinical Trial Update: The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Onglyza (saxagliptin) for effects on glucose fluctuation and immune regulation in patients with Type 1 diabetes. The trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Onglyza (Saxagliptin)

Snippet

Sponsor: Nanjing Medical University | Conditions: Type 1 Diabetes | Phase 4 | Status: UNKNOWN